CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ)
2025-06-30 | 2024-09-30 | 2024-06-30 | ||
|---|---|---|---|---|
| Revenues | - | - | 8 | |
| Cost of revenues | - | - | 3.2 | |
| Gross profit | - | - | 4.8 | |
| Selling, general and administrative | 731.517 | 498.607 | 676.086 | |
| Research and development | 501.261 | 581.796 | 924.749 | |
| Amortization of patent costs | 30.742 | 29.271 | 29.271 | |
| Total expenses | 1,263.52 | 1,109.674 | 1,630.106 | |
| Operating loss | -1,263.52 | -1,109.674 | -1,625.306 | |
| Interest income | 30.217 | 69.539 | 67.578 | |
| Total other income (expense) | 30.217 | 69.539 | 67.578 | |
| Loss before provision for income taxes | -1,233.303 | -1,040.135 | -1,557.728 | |
| Provision for income taxes | - | - | - | |
| Net loss | -1,233.303 | -1,040.135 | -1,557.728 | |
| Basic & diluted eps | - | -0.75 | -1.11 | |
| Net loss per share - basic and diluted | -0.48 | - | - | |
| Weighted average number of shares outstanding - basic and diluted | 2,580,532 | - | - | |